Nuzenio

Gene Therapy Shows

Gene Therapy Shows news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Long-Term Follow-Up Shows Safety Signal for OXB-102 Gene Therapy in Parkinson Disease - NeurologyLiveNeurologyLive · Sat, 08 Aug 2026 22:27:33 GMT Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapy - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 15:16:34 GMT Parkinson’s disease: dual-enzyme AAV gene therapy shows clean 12-month safety signal - Vera HealthVera Health · Fri, 07 Aug 2026 01:36:34 GMT Gene therapy shows benefits in all participants in Fabry clinical trial - Fabry Disease NewsFabry Disease News · Thu, 06 Aug 2026 20:18:27 GMT CMS Model Tackles Gene Therapy Access Barriers - BioXconomyBioXconomy · Thu, 06 Aug 2026 16:09:49 GMT Tenaya’s TN-201 Gene Therapy Shows Hypertrophy Reduction in HCM Patients - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMT Kriya Announces Publication of Preclinical Data Showing AAV-FGF21 Gene Therapy Extended Health Span and Lifespan in Aged Mice - BioSpaceBioSpace · Thu, 06 Aug 2026 02:31:45 GMT The ethical perils of gene therapy - Financial TimesFinancial Times · Wed, 05 Aug 2026 04:05:46 GMT

Timeline

Sat, 08 Aug 2026 22:27:33 GMTLong-Term Follow-Up Shows Safety Signal for OXB-102 Gene Therapy in Parkinson Disease - NeurologyLive

Fri, 07 Aug 2026 15:16:34 GMTEnsoma sheds more staff, pauses preclinical programs to home in on lead gene therapy - Fierce Biotech

Fri, 07 Aug 2026 01:36:34 GMTParkinson’s disease: dual-enzyme AAV gene therapy shows clean 12-month safety signal - Vera Health

Thu, 06 Aug 2026 20:18:27 GMTGene therapy shows benefits in all participants in Fabry clinical trial - Fabry Disease News

Thu, 06 Aug 2026 16:09:49 GMTCMS Model Tackles Gene Therapy Access Barriers - BioXconomy

Thu, 06 Aug 2026 06:43:58 GMTTenaya’s TN-201 Gene Therapy Shows Hypertrophy Reduction in HCM Patients - The Clinical Trial Vanguard

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

AAV4 live mentions Fabry Disease News3 live mentions Drug Target Review3 live mentions Progress Educational Trust3 live mentions Managed Healthcare Executive3 live mentions Term Follow2 live mentions Up Shows Safety2 live mentions Signal2 live mentions OXB2 live mentions Gene Therapy2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gene Therapy Shows.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.